These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27557350)

  • 1. Safety of intravenous iron use in chronic kidney disease.
    Kalra PA; Bhandari S
    Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):529-535. PubMed ID: 27557350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
    Qunibi WY
    Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice].
    Rottembourg J; Rostoker G
    Nephrol Ther; 2015 Dec; 11(7):531-42. PubMed ID: 26498106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of intravenous and oral iron in chronic kidney disease.
    Agarwal R; Kusek JW; Pappas MK
    Kidney Int; 2015 Oct; 88(4):905-14. PubMed ID: 26083656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron deficiency anemia in chronic kidney disease: Uncertainties and cautions.
    Agarwal R
    Hemodial Int; 2017 Jun; 21 Suppl 1():S78-S82. PubMed ID: 28403561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the safety of intravenous iron treatments for patients with chronic kidney disease.
    Kassianides X; Hazara AM; Bhandari S
    Expert Opin Drug Saf; 2021 Jan; 20(1):23-35. PubMed ID: 33203251
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-intravenous approaches to iron therapy in chronic kidney disease: will it improve the benefit-to-risk ratio?
    Besarab A
    Nephrol News Issues; 2014 Feb; 28(2):12, 14-5. PubMed ID: 24649747
    [No Abstract]   [Full Text] [Related]  

  • 8. [Iron therapy in chronic kidney disease].
    Graczyk M; Kohmann A
    Wiad Lek; 2016; 69(5):749-752. PubMed ID: 28033601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease.
    Aksan A; Işık H; Radeke HH; Dignass A; Stein J
    Aliment Pharmacol Ther; 2017 May; 45(10):1303-1318. PubMed ID: 28326596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia.
    Dossabhoy NR; Turley S; Gascoyne R; Tapolyai M; Sulaiman K
    Ren Fail; 2014 Aug; 36(7):1033-7. PubMed ID: 24845687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron administration is associated with reduced platelet counts in patients with chronic kidney disease.
    Hazara AM; Bhandari S
    J Clin Pharm Ther; 2015 Feb; 40(1):20-3. PubMed ID: 25302541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on intravenous iron choices.
    Larson DS; Coyne DW
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):186-91. PubMed ID: 24401789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease.
    Coyne DW
    Expert Opin Pharmacother; 2009 Oct; 10(15):2563-8. PubMed ID: 19708851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Oral and Intravenous Iron.
    DeLoughery TG
    Acta Haematol; 2019; 142(1):8-12. PubMed ID: 30970354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single total dose infusion of ferumoxytol (1020 mg in 30 minutes) is an improved method of administration of intravenous iron.
    Karki NR; Auerbach M
    Am J Hematol; 2019 Sep; 94(9):E229-E231. PubMed ID: 31155744
    [No Abstract]   [Full Text] [Related]  

  • 16. Iron therapy for managing anaemia in chronic kidney disease.
    Macdougall IC
    Curr Opin Nephrol Hypertens; 2018 Sep; 27(5):358-363. PubMed ID: 29905580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme iron polypeptide for the management of anaemia of chronic kidney disease.
    Dull RB; Davis E
    J Clin Pharm Ther; 2015 Aug; 40(4):386-90. PubMed ID: 25953602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of ferumoxytol in hemodialysis patients at 3 dialysis chains in the United States over a 12-month period.
    Schiller B; Bhat P; Sharma A
    Clin Ther; 2014 Jan; 36(1):70-83. PubMed ID: 24315802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous iron supplementation in chronic kidney disease: an update.
    Macdougall IC; Geisser P
    Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron Therapy in Inflammatory Bowel Disease.
    Kumar A; Brookes MJ
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33198376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.